TOLEDOMIN Side Effects

6228581-6 | Cataract, Somnolence
on Jun 03, 2009 Female patient from JAPAN , 60 years of age, was diagnosed with depression (What is depression?), anxiety disorder and was treated with Toledomin (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), somnolence. Toledomin dosage: Unk. During the same period patient was treated with RESLIN (Unk) (View Reslin Review and Reslin Label ), LORAMET (Unk) (View Loramet Review and Loramet Label ), WYPAX (Unk) (View Wypax Review and Wypax Label ), MYSLEE (5 Mg) (View Myslee Review and Myslee Label ), SEROQUEL (50 Mg) (View Seroquel Review and Seroquel Label ).

5542483-X | Hepatic Function Abnormal
Patient was taking Toledomin (View Usage). Patient had the following side effects: hepatic function abnormal on Nov 29, 2007 from JAPAN Additional patient health information: Female patient , 39 years of age, was diagnosed with insomnia, depression (What is depression?) and. Toledomin dosage: . During the same period patient was treated with SEPAZON (View Sepazon Review and Sepazon Label ), SILECE (2 Mg Qd To Qid) (View Silece Review and Silece Label ), SEROQUEL (100 Mg) (View Seroquel Review and Seroquel Label ), HALCION (0.25 Mg Qd To Qid) (View Halcion Review and Halcion Label ). Patient was hospitalized.

5145821-5 | Erythema Multiforme
Adverse event was reported on Oct 19, 2006 by a Female patient taking Toledomin (View Usage) (Dosage: 50 Mg/day) . Location: JAPAN , 39 years of age, After Toledomin was administered, patient had the following side effects: erythema multiforme. During the same period patient was treated with DEPAS (1.5 Mg) (View Depas Review and Depas Label ), LUDIOMIL (30 Mg/day) (View Ludiomil Review and Ludiomil Label ).

5069231-4 | Completed Suicide, Intentional Overdose, Suicide Attempt
on Jul 25, 2006 Male patient from JAPAN , 39 years of age, was diagnosed with bipolar i disorder and was treated with Toledomin (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, intentional overdose, suicide attempt. Toledomin dosage: Unk, Unk. During the same period patient was treated with MEILAX (Unk, Unk) (View Meilax Review and Meilax Label ), TEGRETOL (Unk, Unk) (View Tegretol Review and Tegretol Label ).


5066231-5 | Suicide Attempt
on Jul 25, 2006 Male patient from JAPAN , 39 years of age, was treated with Toledomin (View Usage). Patient had the following side effects: suicide attempt. Toledomin dosage: . During the same period patient was treated with MEILAX (View Meilax Review and Meilax Label ), TEGRETOL (14000 Mg) (View Tegretol Review and Tegretol Label ).

4609987-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Hepatitis C Antibody Positive
Patient was taking Toledomin (View Usage). After Toledomin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, hepatitis c antibody positive on Mar 10, 2005 from Additional patient health information: Female patient , 46 years of age, was diagnosed with nail tinea and. Toledomin dosage: . During the same period patient was treated with REMICUT (View Remicut Review and Remicut Label ), MYSLEE (View Myslee Review and Myslee Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), LAMISIL (125 Mg/d) (View Lamisil Review and Lamisil Label ).